Discover open access scientific publications

Search, annotate, share and cite publications

Publications by B Brueggenjuergen

Cost-Effectiveness of Edoxaban Compared With Other Licensed Noacs for the Prevention of Stroke and Systemic Embolic Events in the Uk

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Related publications

Pcv80 - Cost-Effectiveness of Noacs in Prevention of Stroke and Systemic Embolism in the Czech Republic

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The Cost-Effectiveness of Dabigatran Etexilate Compared With Edoxaban in the Treatment of Acute Venous Thromboembolism in the Uk

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Cost-Effectiveness of New Oral Anticoagulants Compared With Warfarin in Preventing Stroke and Other Cardiovascular Events in Patients With Atrial Fibrillation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Pcv84 - Cost-Effectiveness Analysis of Apixaban Versus Edoxaban for Stroke Prevention in Non-Valvular Atrial Fibrillation Spanish Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The Potential Role of Edoxaban in Stroke Prevention Guidelines

Arrhythmia and Electrophysiology Review
Cardiovascular MedicinePhysiologyCardiology
2011English

Cost-Effectiveness of Apixaban Compared With Aspirin for Stroke Prevention in Atrial Fibrillation Among Patients Unsuitable for Warfarin

Circulation. Cardiovascular quality and outcomes
MedicineCardiovascular MedicineCardiology
2012English

Estimating the Cost-Effectiveness of Stroke Units in France Compared With Conventional Care

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2004English

NAVIGATE ESUS: Phase-Iii RCT Assessing Prevention of Stroke and Systemic Embolism in Patients With Embolic Stroke of Undetermined Source

Journal of the Neurological Sciences
Neurology
2015English

Pcv53 - Is Edoxaban More Cost-Effective Than Warfarin in Prevention of Stroke and Deep Vein Thrombosis?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy